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Abstract
Background: The spectrum of Kaposi's sarcoma (KS) has been expanded to include pre-KS
lesions.
Case Presentation: We report, for the first time, a case providing direct histological evidence of
the development of early (in-situ) KS from mediastinal lymphatic vessels in the setting of chronic
lymphedema in an HIV-positive patient. Spindle-shaped and endothelial cells in these early KS-
appearing lesions were immunoreactive for HHV8, D2-40 and CD34.
Conclusion:  Our findings suggest that HHV8-infected spindle-shaped cells associated with
lymphangiogenesis that evolve into KS lesions, acquire from the outset an aberrant mixed vascular
and lymphatic endothelial cell phenotype.
Background
Kaposi's sarcoma (KS) is a vascular neoplasm that may
involve mucocutaneous and visceral body sites. KS lesions
are comprised of aberrant vessels and spindle-shaped
tumor cells that increases in frequency from an early patch
and plaque and ultimately establishes a tumor (nodular
stage). Several lines of evidence support a lymphatic
endothelial origin of Kaposi's sarcoma (KS) [1]. Specifi-
cally, KS spindle cells react with monoclonal antibodies to
VEGFR-3 (the extracellular domain of the vascular
endothelial growth factor-C receptor), which is a marker
for lymphatic endothelial cells [2]. The D2-40 antibody is
another selective marker of lymphatic endothelium and
similarly reacts with KS lesional cells at all stages of pro-
gression, supporting the concept that KS originates from a
stem cell capable of undergoing lymphatic differentiation
[3]. Finally, infection of differentiated blood vascular
endothelial cells with human herpesvirus-8 (HHV8) has
been demonstrated to induce lymphatic lineage-specific
genes with concomitant down regulation of blood vascu-
lar genes [4].
The spectrum of KS lesions has been expanded to include
pre-KS, a lymphedematous form of KS [5]. We report a
case that provides clear histological evidence of the devel-
opment of such early (in-situ) KS with immunohisto-
chemical verification.
Case presentation
A 34-year-old homosexual male with acquired immune
deficiency syndrome (AIDS)-related KS presented with
chylothoraces due to obstruction of his thoracic duct by
KS. He had extensive cutaneous lesions on the face, fore-
head, upper torso, mid-abdomen, left arm and left flank.
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He had been initially diagnosed with AIDS when he pre-
sented with vomiting and bloody diarrhea, and was found
via endoscopy to have KS involving the colon. HIV serol-
ogy was positive and his CD4 T-lymphocyte count at diag-
nosis was 30 cells/mm3. He was subsequently found via
bronchoscopy to have pulmonary KS.
Pleuroperitoneal shunt placement and thoracic duct liga-
tion were performed for management of chylothoraces.
Since placement of the shunt, he developed ascites with
subcutaneous extravassation of lymph that was associated
with xanthogranulomatous bile lakes (Figure 1). He
received diuretic therapy and medium-chain triglyceride
dietary supplementation with only temporary improve-
ment of his ascites. He was requiring paracentesis every 4–
6 weeks for resolution of respiratory distress.
He received highly active antiretroviral therapy (stavu-
dine, lamivudine and nelfinavir) and his HIV viral load
became undetectable. His KS was treated initially with
liposomal daunorubicin and then paclitaxel. He was then
switched to SU5416 (an angiogenesis inhibitor) to which
he had a temporary response. He was placed on palliative
paclitaxel and died of progressive KS about 18 months
later.
His pleural and lung biopsies showed dilated pleuropul-
monary lymphatics (Figure 2) with interstitial pulmonary
extravassation of lymph. The biopsy revealed a multifocal
increase in spindle-shaped cells with neo-angiogenesis
originating from dilated lymphatics, associated with scat-
tered lymphocytes and hemosiderin-laden macrophages,
resembling early stage KS (Figure 3).
Immunohistochemistry was performed using HHV8 asso-
ciated Latent Nuclear Antigen-1 (LNA-1; Advanced Bio-
technologies, Columbia, MD) monoclonal antibody, as
well as dual-color immunostaining with the vascular
endothelial marker CD34 (Dako, Carpinteria, CA) and
lymphatic specific endothelial marker D2-40 (Signet,
Dedham, MA). Spindle-shaped and endothelial cells in
these early KS-appearing regions were strongly HHV8 pos-
itive (Figure 4) and immunoreactive for both D2-40 and
CD34 (Figure 5). Non-lesional lymphatics were HHV8
negative and only D2-40 positive. Native blood vessel
endothelium was HHV8 and D2-40 negative, and only
CD34 positive.
Conclusion
We believe that the findings in this case provide direct
morphological evidence of the development of an in-situ
form of KS directly from lymphatics in the setting of
chronic lymphedema. Our results are consistent with pre-
vious reports of a cutaneous lymphedematous form of
pre-KS [5,6]. In our patient, chronic lymphedema
together with HHV8 infection of lymphatic endothelial
cells probably led to the development of KS in-situ
lesions. This is in concordance with previous reports
Dilated lymphatics with multifocal areas resembling early KS  (H&E stain, magnification ×100) Figure 2
Dilated lymphatics with multifocal areas resembling early KS 
(H&E stain, magnification ×100).
Subcutaneous bile lake with associated xanthogranulomatous  reaction (H&E stain, magnification ×100) Figure 1
Subcutaneous bile lake with associated xanthogranulomatous 
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howing that chronic lymphedema may predispose for
local immune incompetence, manifested by the develop-
ment of KS and Stewart-Treves syndrome (lymphangiosa-
rcoma arising from chronic lymphedema) [7-9]. Chronic
lymphedema may occasionally mask the presence of KS
while the co-existence of smaller fibroma-like nodules
which are frequently associated with chronic lymphe-
dema have the potential to acquire the characteristics of
KS [10]. The histological findings in our case were not as
exuberant as those reported in the lymphangioma-like
variant of KS [11], nor was there any cytological atypia
reminiscent of lymphangiosarcoma. Of note, the develop-
ment of KS from local lymphedema has been reported
even in a patient without immunosuppression or HIV
infection, who was nevertheless HHV8 seropositive [8].
While bile is well known to have the capability of evoking
a xanthogranulomatous reaction, the histopathological
findings of subcutaneous xanthogranulomatous bile
lakes, as demonstrated in this case, has not been previ-
ously reported [12]. Chylothorax is a known but rare
manifestation of KS involving the thoracic duct and adja-
cent mediastinal structures [13,14]. Rare cases of chylous
ascites caused by KS have also been noted [15]. Although
KS-related chylothorax has been postulated to develop
due to metastatic KS of the thoracic duct [16], our findings
suggest that chylothorax may arise due to development of
in-situ KS in this region. Finally, our findings further indi-
cate that HHV-8-infected spindle-shaped cells that evolve
into KS lesions acquire, from the outset, an aberrant
mixed vascular and lymphatic endothelial cell phenotype
as evident by the coexpression of CD34 and D2-40 on
lesional cells.
In situ KS lesional cells focally co-express CD34 (brown) and  D2-40 (red) Figure 5
In situ KS lesional cells focally co-express CD34 (brown) and 
D2-40 (red).
KS in-situ area at higher magnification comprised of small  vessels and adjacent spindled cells arising from dilated lym- phatics (H&E stain, magnification ×400) Figure 3
KS in-situ area at higher magnification comprised of small 
vessels and adjacent spindled cells arising from dilated lym-
phatics (H&E stain, magnification ×400).
HHV8 positive cells lining dilated lymphatics and focal spin- dle-shaped cells (LNA-1 immunohistochemical stain; magnifi- cation ×400) Figure 4
HHV8 positive cells lining dilated lymphatics and focal spin-
dle-shaped cells (LNA-1 immunohistochemical stain; magnifi-
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